KREBSBEHANDLUNG

European patent · EP2920308 · In force

Register entry

Publication number
EP2920308
Application number
EP13850047
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Oct 30, 2013
Published
Sep 23, 2015
Granted
Dec 12, 2018
Protection ends at the latest
Oct 29, 2033
Next annual fee due
Oct 31, 2026
IPC classes
C12N 15/113 (2010.01)
A61P 35/00 (2006.01)
Priority
US 201261720939 P 31.10.2012
US 201361777875 P 12.03.2013
PCT application
PCT/US2013/067469 30.10.2013
PCT publication
WO2014/070868 08.05.2014
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 6, 2026

    Change

    Published in Swissreg on 06.01.2026

  2. Nov 1, 2024

    Change

    Published in Swissreg on 01.11.2024

  3. Nov 1, 2023

    Change

    Published in Swissreg on 01.11.2023

  4. Jan 11, 2023

    Change

    Published in Swissreg on 11.01.2023

  5. Dec 19, 2018

    Granted

    Published in Swissreg on 19.12.2018

Parties

Holder

Ionis Pharmaceuticals, Inc.

2855 Gazelle Court, Carlsbad, CA 92010, US

Inventor

YAMASHITA, Mason

Carlsbad, CA 92010, US

CROOKE, Stanley, T.

Carlsbad, CA 92010, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.